Experience in treatment of metastatic pulmonary carcinoid tumors

Annals of Oncology

Volumn 12, Issue 10, 2001, Pages 1383-1391

  Granberg, D ^a   Eriksson, B ^a   Wilander, E ^a   Grimfjard P ^a   Fjallskog M L ^a   Oberg K ^a   Skogseid, B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alpha interferon; Chemotherapy; Octreotide; Pulmonary carcinoids

Indexed keywords

ALPHA INTERFERON; ANGIOPEPTIN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CHROMOGRANIN A; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GAMMA INTERFERON; HORMONE; OCTREOTIDE; PACLITAXEL; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DRUG RESPONSE; EXPERIENCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; PRIORITY JOURNAL; SIDE EFFECT; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOID TUMOR; CISPLATIN; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; SOMATOSTATIN; STREPTOZOCIN; SURVIVAL ANALYSIS;

EID: 0035190131     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012569909313     Document Type: Article

References (25)

1. Atypical carcinoid tumors of the lung
2. Carcinoid and other neuroendocrine tumors. Tumors of the lower respiratory tract, atlas of tumor pathology
3. Bronchial carcinoid tumors
4. Carcinoid tumors of the lung
5. Bronchial carcinoids - Review of 124 cases
6. Carcinoid tumors. An analysis of 2837 cases
7. Bronchial carcinoid - Twenty years' experience defines a selective surgical approach
8. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid
9. Fragments of chromogranin A are present in the urine of patients with carcinoid tumors: Development of a specific radioimmunoassay for chromogranin A and its fragments
10. Measurement of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours
11. Serum levels of human pancreatic polypeptide in renal disease
12. Serum calcitonin in medullary thyroid carcinoma
13. HCG and HCG-subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids
14. Histamine metabolism in carcinoidosis
15. Prognostic markers in patients with typical bronchial carcinoid tumors
16. Secretion of chromogranin A by peptide-producing endocrine neoplasms
17. Clinical symptoms, hormone profiles, treatment and prognosis in patients with gastric carcinoids
18. Plasma chromogranin A in patients with multiple endocrine neoplasia type 1
19. Combination therapy with octreotide and α-interferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors
20. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors
21. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma
22. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms
23. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors
24. Typical and atypical bronchial carcinoids